ATAI Life Sciences N.V (NASDAQ:ATAI) currently has a daily average trading volume of 1.06M but it saw 1257189 shares traded in last market. With a market cap of 255.06M USD, the company’s current market price of $1.52 came falling about -4.40 while comparing to the previous closing price of $1.59. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.85 and as low as $1.02. In the recent trading on the day, stock has struck highest price mark of $1.51 while lowest mark touched by it was $1.6.
Taking a look at 20-day trading activity of ATAI Life Sciences N.V (ATAI) gives us an average price of $1.3370, while its current price level is -46.67% below from 52-week high level whereas it is 48.29% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.2408 while that of 200 days or SMA-200 reads an average of $1.5563. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.80% during that period while stretching the period over a month that decreases to 12.67%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 57.65 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which reiterated the stock as “Buy” in its note to investors issued on November 18, 2024, recommending a price target of between $15 and $10 for it. Maxim Group upgraded its recommendation for the stock as a “Buy” from “Hold” on April 03, 2024 while assigning a price target of $6. Loop Capital issued its recommendations for the stock as it initiated the price target for the stock is $18.
Over the week, ATAI’s stock price is moving 10.95% up while it is 25.62% when we observe its performance for the past one month. Year-to-date it is 7.80% up and over the past year, the stock is showing an upside performance of 42.06%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.12 beat the consensus estimate of -0.16 for the same. The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of -0.15 while estimate for next year EPS is -0.76. Moreover, analysts are in estimates of $250k for current-quarter revenue.
Currently, ATAI Life Sciences N.V’s total number of outstanding shares is 166.03M with 9.99% of that held by the insiders while 26.81% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -77.07% and return on equity (ROE) at -62.43%. Stock’s beta reads 0.94. Stock has a price to book (P/B) ratio of 1.75 while price to sale or P/S ratio amounts to 772.91. Its return on asset (ROA) is -50.86% on average.
